Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered Through Systematic Combination Screening
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0925
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2012
Authors
Publisher
American Association for Cancer Research (AACR)